IDEX Corp
NYSE:IEX
IDEX Corp
IDEX Corporation, a name heralded in the world of fluidics and engineered solutions, traces its lineage back to 1988, when it was founded with the vision of melding innovation with precision. Since then, it has carved out a niche in the manufacture of a diverse range of products, from pumps and flow meters to sophisticated health and science technologies. Headquartered in Northbrook, Illinois, IDEX stands out through its decentralized operating model, allowing its individual business units the freedom to tailor solutions that meet specific customer needs across various industries. This strategic flexibility enables IDEX to swiftly respond to market demands and capitalize on specialized opportunities.
The company’s revenue streams are as varied as its product offerings. IDEX generates income principally through the sale of highly engineered products that are critical to a vast array of applications, from life sciences and medical instruments to fire and safety equipment. The company's growth is further fueled by its strategy of acquiring smart and complementary businesses that enhance its product portfolio and market reach. By focusing on niche markets where performance and reliability are paramount, IDEX not only fortifies its competitive position but also ensures a steady flow of profits from customers who rely on their precision-engineered solutions.
IDEX Corporation, a name heralded in the world of fluidics and engineered solutions, traces its lineage back to 1988, when it was founded with the vision of melding innovation with precision. Since then, it has carved out a niche in the manufacture of a diverse range of products, from pumps and flow meters to sophisticated health and science technologies. Headquartered in Northbrook, Illinois, IDEX stands out through its decentralized operating model, allowing its individual business units the freedom to tailor solutions that meet specific customer needs across various industries. This strategic flexibility enables IDEX to swiftly respond to market demands and capitalize on specialized opportunities.
The company’s revenue streams are as varied as its product offerings. IDEX generates income principally through the sale of highly engineered products that are critical to a vast array of applications, from life sciences and medical instruments to fire and safety equipment. The company's growth is further fueled by its strategy of acquiring smart and complementary businesses that enhance its product portfolio and market reach. By focusing on niche markets where performance and reliability are paramount, IDEX not only fortifies its competitive position but also ensures a steady flow of profits from customers who rely on their precision-engineered solutions.
Order Momentum: IDEX reported strong Q4 organic orders growth of 16%, with a standout 34% growth in its Health & Science Technologies (HST) segment.
Revenue & Margins: Organic sales grew 1% in Q4, with adjusted EBITDA margin expanding 40 basis points year-over-year due to price, productivity, and cost actions.
HST Strength: HST saw record orders and 5% organic sales growth, fueled by demand from data centers, semiconductors, space, and defense; about half of the HST backlog is tied directly to data center applications.
Outlook 2026: Management expects 1% to 2% organic growth overall in 2026, driven by mid-single-digit growth in HST and flat-to-down trends in other segments; adjusted EPS guidance is $8.15 to $8.35.
Capital Allocation: IDEX generated $617 million in free cash flow in 2025, reduced leverage, and repurchased nearly $250 million in shares, with similar repurchase activity planned for 2026.
Market Trends: Industrial and auto remain soft; no clear inflection in demand yet, but IDEX is positioned to respond quickly if growth returns.
Pricing: Price contributed about 3% to Q4 sales and is expected to add 1% to 2% in 2026.
